Bioluminescent kinase strips: A novel approach to targeted and flexible kinase inhibitor profiling

被引:9
|
作者
Hennek, J. [1 ,4 ]
Alves, J. [1 ]
Yao, E. [2 ]
Goueli, S. A. [1 ,3 ]
Zegzouti, H. [1 ]
机构
[1] Promega Corp, R&D Dept, Madison, WI 53711 USA
[2] SignalChem Pharmaceut, Richmond, BC V6V 2J2, Canada
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53705 USA
[4] Exact Sci, Madison, WI 53719 USA
关键词
Kinase profiling; Bioluminescence; ADP detection; Selectivity profiles; Kinase assay; Kinase inhibitor; CHRONIC MYELOGENOUS LEUKEMIA; PROTEIN-KINASE; RHEUMATOID-ARTHRITIS; DRUG DISCOVERY; SELECTIVITY; ASSAY; MOUSE; MAP; CK2; GLOMERULONEPHRITIS;
D O I
10.1016/j.ab.2015.11.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In addition to target efficacy, drug safety is a major requirement during the drug discovery process and is influenced by target specificity. Therefore, it is imperative that every new drug candidate be profiled against various liability panels that include protein kinases. Here, an effective methodology to streamline kinase inhibitor profiling is described. An accessible standardized profiling system for 112 protein kinases covering all branches of the kinome was developed. This approach consists of creating different sets of kinases and their corresponding substrates in multi-tube strips. The kinase stocks are pre-standardized for optimal kinase activity and used for inhibitor profiling using a bioluminescent ADP detection assay. We show that these strips can routinely generate inhibitor selectivity profiles for small or broad kinase family panels. Lipid kinases were also assembled in strip format and profiled together with protein kinases. We identified two specific PI3K inhibitors that have off-target effects on CK2 that were not reported before and would have been missed if compounds were not profiled against lipid and protein kinases simultaneously. To validate the accuracy of the data generated by this method, we confirmed that the inhibition potencies observed are consistent with published values produced by more complex technologies such as radioactivity assays. (C) 2015 The Authors. Published by Elsevier Inc.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 50 条
  • [1] A Flexible Workflow for Automated Bioluminescent Kinase Selectivity Profiling
    Worzella, Tracy
    Butzler, Matt
    Hennek, Jacquelyn
    Hanson, Seth
    Simdon, Laura
    Goueli, Said
    Cowan, Cris
    Zegzouti, Hicham
    SLAS TECHNOLOGY, 2017, 22 (02): : 153 - 162
  • [2] Profiling MAP kinase cysteines for targeted covalent inhibitor design
    Liu, Ruibin
    Verma, Neha
    Henderson, Jack A.
    Zhan, Shaoqi
    Shen, Jana
    RSC MEDICINAL CHEMISTRY, 2022, 13 (01): : 54 - 63
  • [3] Targeted Kinase Selectivity from Kinase Profiling Data
    Milletti, Francesca
    Hermann, Johannes C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (05): : 383 - 386
  • [4] ON 108110, a novel kinase inhibitor: Description of the synthesis, kinase profiling, and co-crystal structure
    Subbaiah, D. R. C. Venkata
    Pallela, Venkat R.
    Padgaonkar, Amol
    Rechkoblit, Olga
    Patti, Revathi
    Billa, Vinaykumar
    Mallireddigari, Muralidhar R.
    Akula, Balaiah
    Cosenza, Stephen C.
    Aggarwal, Aneel
    Reddy, E. Premkumar
    Reddy, M. V. Ramana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [5] Bioluminescent dehydrogenase assays: A novel approach for metabolic profiling and inhibitor screening in cancer biology
    Haupt, Kim
    Karassina, Natasha
    Lauer, Anthony
    Sylvester, Kayla
    Vidugiriene, Jolanta
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor
    Tiwari, Shruti Rakesh
    Mishra, Prasun
    Abraham, Jame
    CLINICAL BREAST CANCER, 2016, 16 (05) : 344 - 348
  • [7] Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling
    Fang, Bin
    Haura, Eric B.
    Smalley, Keiran S.
    Eschrich, Steven A.
    Koomen, John M.
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 739 - 747
  • [8] Identification of a novel inhibitor of MAP kinase kinase (MEK)
    Manos, EJ
    Favata, MF
    Daulerio, AJ
    Stradley, DA
    Feeser, WS
    Horiuchi, K
    Copeland, RA
    Scherle, PA
    Trzaskos, JM
    FASEB JOURNAL, 1997, 11 (09): : A1357 - A1357
  • [9] Profiling Kinase Pathway Activation and Inhibitor Activity Using a Novel Antibody Array
    Radding, Jeffrey Alan
    Rauh-Adelmann, Christine
    Hall, Amy B.
    Murphy, Cheryl
    Yen, Lucy G.
    Graham, James R.
    Nadler, Timothy K.
    Gordon, Neal F.
    FASEB JOURNAL, 2008, 22
  • [10] Kinase selectivity profiling by inhibitor affinity chromatography
    Valsasina, B
    Kalisz, HM
    Isacchi, A
    EXPERT REVIEW OF PROTEOMICS, 2004, 1 (03) : 303 - 315